Lung Cancer & COVID-19 Webinar.

December 20, 2020

Author: Acteropharma

Regarding the Importance of experience sharing about Lung cancer patients with COVID-19 complications, a multidisciplinary virtual Meeting was held on December 3rd 2020, with the topic of “Lung Cancer & COVID19” with the presence of Dr. Khosravi (Medical Oncologists), Dr. Seifi (Medical Oncologists), Dr. Salimi (Medical Oncologists), Dr. Kiani (Pulmonologist), Dr. Naseri (Radio Oncologist), Dr. Bakhshayesh karam (Radiologist), Dr. Daneshvar (Thoracic Surgeon).

Erlotinib ACTe & Pemetrexed ACTe are two ACTERO’s products, which has a certain position in lung cancer treatment.

Last News

June 1, 2024


International Nurse Day
May 12, 2024


May 12th is celebrated as International Nurses Day, in order to appreciate nurses from all over the world. Actero Company has always appreciated the efforts of the country’s dear nurses, for this reason, on this day, express our gratitude to these honorable people.
Actero futsal match
May 8, 2024


Today, the role of exercise in reducing the risk of some cancers is not hidden from anyone. Exercise has many biological effects on the body. These include: decrease in the level of sex hormones such as estrogen and growth factors that are related to the development and progression of cancer. Physical activity can be helpful in order to lose weight or maintain a healthy weight, which reduces the risk of some types of cancer. Being active is important; It keeps your body and mind healthy, prevents disease and has many benefits. According to this important matter, Actero company invited its employees to participate in sports activities for a healthy future by holding an internal futsal competition between the headquarters team and the factory team.